Company ProfilePremium

Guardant Health

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Guardant Health - Healthcare showcase

Year Founded & Workforce

2013

622 Employees

Industry

Healthcare

Services

Solutions
G

Guardant Health Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Guardant Health Overview

Company Headquarters: California, US

Founded: 2013

Workforce: 622+

Company Working: Guardant Health (Guardant) is one of the leading precision oncology companies that is focused on helping conquer cancer globally through the use of its proprietary blood-based tests, vast data sets and advanced analytics. The company has provided its offerings to more than 5,000 oncologists, over 40 biopharmaceutical companies, and all 27 of the National Comprehensive Cancer Network centers. The company operates its business through two main geographical segments- the US and International.

Strategy

Guardant is focused on becoming the leading provider of precision oncology products for cancer management across all stages of the disease and drive commercial adoption of our products. It is also focused on increasing the awareness of its products, expanding clinical utility & increasing reimbursement for its products, strengthening its relationship with biopharmaceutical & academic customers, and leverage the guardant health oncology platform to expand its product portfolio.

Company Snapshot

$49.8M

Revenue

622

Employees

2013

Founded

California, US

Headquarters

SWOT Analysis

Strengths

  • High R&D investment

Weaknesses

  • Negative operating profit
  • High dependence on the US market

Opportunities

  • Investing in mergers & acquisitions to expand in the companion diagnostics market

Threats

  • Stringent government regulations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Guardant Health
    • Solutions

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 49.8 Mn in 2017 to USD 214.4 Mn in 2019.
Guardant Health — By Business Segment
Series (USD Mn)201720182019
Sales49.890.6214.4
R&D25.650.786.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.